Nicotinic acid: Treatment for the hyperchloremic acidosis following urinary diversion through intestinal segments

Michael Koch, W. S. McDougal

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The syndrome of hyperchloremic metabolic acidosis following urinary diversion through intestinal segments has posed a problem for urologists for more than 50 years. Recent work demonstrates that chlorpromazine, an intestinal cyclic-AMP inhibitor, partially corrects the metabolic derangements associated with this syndrome. Nicotinic acid has also been shown to be a potent inhibitor of intestinal cyclic-AMP. The present investigation employs nicotinic acid in a rat vesico-cecostomy model to examine its efficacy in the management of this syndrome. Rats with vesico-cecostomies treated with nicotinic acid are compared to untreated rats, rats with intestinal but not urinary diversions and non-operative controls. Nicotinic acid in a dose of 50 mg./kg./day corrects the hyperchloremia (p <0.02), elevated serum osmolality (p <0.0001), hyperammoniumemia (p <0.05) and acidosis (p <0.001). Results compare favorably to those obtained in an identical model with the use of chlorpromazine.

Original languageEnglish (US)
Pages (from-to)162-164
Number of pages3
JournalJournal of Urology
Volume134
Issue number1
StatePublished - 1985
Externally publishedYes

Fingerprint

Urinary Diversion
Niacin
Acidosis
Cecostomy
Chlorpromazine
Cyclic AMP
Therapeutics
Osmolar Concentration
Serum

ASJC Scopus subject areas

  • Urology

Cite this

Nicotinic acid : Treatment for the hyperchloremic acidosis following urinary diversion through intestinal segments. / Koch, Michael; McDougal, W. S.

In: Journal of Urology, Vol. 134, No. 1, 1985, p. 162-164.

Research output: Contribution to journalArticle

@article{d02685dda3934bd7a188498c388056a7,
title = "Nicotinic acid: Treatment for the hyperchloremic acidosis following urinary diversion through intestinal segments",
abstract = "The syndrome of hyperchloremic metabolic acidosis following urinary diversion through intestinal segments has posed a problem for urologists for more than 50 years. Recent work demonstrates that chlorpromazine, an intestinal cyclic-AMP inhibitor, partially corrects the metabolic derangements associated with this syndrome. Nicotinic acid has also been shown to be a potent inhibitor of intestinal cyclic-AMP. The present investigation employs nicotinic acid in a rat vesico-cecostomy model to examine its efficacy in the management of this syndrome. Rats with vesico-cecostomies treated with nicotinic acid are compared to untreated rats, rats with intestinal but not urinary diversions and non-operative controls. Nicotinic acid in a dose of 50 mg./kg./day corrects the hyperchloremia (p <0.02), elevated serum osmolality (p <0.0001), hyperammoniumemia (p <0.05) and acidosis (p <0.001). Results compare favorably to those obtained in an identical model with the use of chlorpromazine.",
author = "Michael Koch and McDougal, {W. S.}",
year = "1985",
language = "English (US)",
volume = "134",
pages = "162--164",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Nicotinic acid

T2 - Treatment for the hyperchloremic acidosis following urinary diversion through intestinal segments

AU - Koch, Michael

AU - McDougal, W. S.

PY - 1985

Y1 - 1985

N2 - The syndrome of hyperchloremic metabolic acidosis following urinary diversion through intestinal segments has posed a problem for urologists for more than 50 years. Recent work demonstrates that chlorpromazine, an intestinal cyclic-AMP inhibitor, partially corrects the metabolic derangements associated with this syndrome. Nicotinic acid has also been shown to be a potent inhibitor of intestinal cyclic-AMP. The present investigation employs nicotinic acid in a rat vesico-cecostomy model to examine its efficacy in the management of this syndrome. Rats with vesico-cecostomies treated with nicotinic acid are compared to untreated rats, rats with intestinal but not urinary diversions and non-operative controls. Nicotinic acid in a dose of 50 mg./kg./day corrects the hyperchloremia (p <0.02), elevated serum osmolality (p <0.0001), hyperammoniumemia (p <0.05) and acidosis (p <0.001). Results compare favorably to those obtained in an identical model with the use of chlorpromazine.

AB - The syndrome of hyperchloremic metabolic acidosis following urinary diversion through intestinal segments has posed a problem for urologists for more than 50 years. Recent work demonstrates that chlorpromazine, an intestinal cyclic-AMP inhibitor, partially corrects the metabolic derangements associated with this syndrome. Nicotinic acid has also been shown to be a potent inhibitor of intestinal cyclic-AMP. The present investigation employs nicotinic acid in a rat vesico-cecostomy model to examine its efficacy in the management of this syndrome. Rats with vesico-cecostomies treated with nicotinic acid are compared to untreated rats, rats with intestinal but not urinary diversions and non-operative controls. Nicotinic acid in a dose of 50 mg./kg./day corrects the hyperchloremia (p <0.02), elevated serum osmolality (p <0.0001), hyperammoniumemia (p <0.05) and acidosis (p <0.001). Results compare favorably to those obtained in an identical model with the use of chlorpromazine.

UR - http://www.scopus.com/inward/record.url?scp=0021824740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021824740&partnerID=8YFLogxK

M3 - Article

C2 - 4009816

AN - SCOPUS:0021824740

VL - 134

SP - 162

EP - 164

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -